Extracellular vesicles derived from mesenchymal stem cells alleviate renal fibrosis via the miR-99b-5p/mTOR/autophagy axis in diabetic kidney disease
Rongrong Li,
No information about this author
Hongyan Tao,
No information about this author
Kai Pan
No information about this author
et al.
Stem Cell Research & Therapy,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 18, 2025
Diabetic
kidney
disease
(DKD)
is
the
leading
cause
of
end-stage
renal
(ESRD)
globally,
presenting
a
significant
therapeutic
challenge.
Extracellular
vesicles
(EVs)
from
mesenchymal
stem
cells
(MSCs)
have
emerged
as
promising
agents.
This
study
explored
effects
and
mechanisms
EVs
derived
human
placental
(hP-MSCs)
on
DKD.
were
isolated
cultured
hP-MSCs
administered
to
streptozotocin
(STZ)-induced
diabetic
mice
high
glucose–treated
glomerular
mesangial
cells.
The
impact
was
assessed
through
histological
analysis
biochemical
assays.
miR-99b-5p
expression
in
its
role
modulating
mechanistic
target
rapamycin
(mTOR)/autophagy
pathway
examined
via
western
blotting
RT‒qPCR.
Treatment
with
hP-MSC-derived
significantly
alleviated
fibrosis
improved
function
DKD
models.
These
enriched
miR-99b-5p,
which
targeted
inhibited
mTOR
signaling,
thereby
increasing
autophagic
activity
reducing
cellular
proliferation
extracellular
matrix
accumulation
tissues.
can
mitigate
injury
by
miR-99b-5p/mTOR/autophagy
pathway.
findings
suggest
potential
cell-free
strategy
for
managing
Language: Английский
Necroptosis: a significant and promising target for intervention of cardiovascular disease
Yanwei Ji,
No information about this author
Xinyu Wen,
No information about this author
He-peng Tang
No information about this author
et al.
Biochemical Pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 116951 - 116951
Published: April 1, 2025
Language: Английский
Regulated Cell Death Pathways in Pathological Cardiac Hypertrophy
Reviews in Cardiovascular Medicine,
Journal Year:
2024,
Volume and Issue:
25(10)
Published: Oct. 11, 2024
Cardiac
hypertrophy
is
characterized
by
an
increased
volume
of
individual
cardiomyocytes
rather
than
increase
in
their
number.
Myocardial
due
to
pathological
stimuli
encountered
the
heart,
which
reduces
pressure
on
ventricular
walls
maintain
cardiac
function,
known
as
hypertrophy.
This
eventually
progresses
heart
failure.
Certain
varieties
regulated
cell
death
(RCD)
pathways,
including
apoptosis,
pyroptosis,
ferroptosis,
necroptosis,
and
autophagy,
are
crucial
development
review
summarizes
molecular
mechanisms
signaling
pathways
underlying
these
RCD
focusing
mechanism
action
findings
for
It
intends
provide
new
ideas
developing
therapeutic
approaches
targeted
at
cellular
level
prevent
or
reverse
Language: Английский
The Potential of Mesenchymal Stem Cell-Derived Exosomes in Cardiac Repair
Dipan Kundu,
No information about this author
Song Yi Shin,
No information about this author
William M. Chilian
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(24), P. 13494 - 13494
Published: Dec. 17, 2024
Cardiovascular
diseases
(CVDs)
are
the
leading
cause
of
death
worldwide,
and
effectively
repairing
heart
following
myocardial
injuries
remains
a
significant
challenge.
Research
has
increasingly
shown
that
exosomes
derived
from
mesenchymal
stem
cells
(MSC-Exo)
can
ameliorate
improve
outcomes
after
such
injuries.
The
therapeutic
benefits
MSC-Exo
largely
due
to
their
capacity
deliver
specific
cargo,
including
microRNAs
proteins.
modulate
various
signaling
pathways
provide
several
beneficial
effects,
cytoprotection,
inflammation
modulation,
angiogenesis
promotion
help
repair
damaged
myocardium.
In
this
review,
we
summarize
cardioprotective
effects
in
injury,
underlying
molecular
mechanism
involved
process,
approaches
studied
enhance
efficacy
based
on
recent
findings.
Language: Английский